{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:12:12Z","timestamp":1783779132982,"version":"3.55.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e a Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This systematic review aimed to describe the work process of pharmaceutical care provided to patients with rheumatoid arthritis (RA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic review was undertaken based on a search of six databases. The protocol was registered in PROSPERO (CRD42020133705). The inclusion criteria were randomized clinical trials (RCTs) with pharmaceutical care as an intervention in patients previously diagnosed with RA. Two investigators independently selected the studies, extracted data, and assessed their methodological quality. The RoB 2 tool was used to evaluate the quality of the studies. A narrative synthesis of results was provided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>A total of 3078 titles were found in the initial search, but only six RCTs, with a total of 337 patients, met the established inclusion criteria. These RCTs had some limitations, and only one had a low risk of bias. In most studies (66.6%), the service performed as an intervention had low complexity, was focused only on health education and did not have an individualized care plan for each patient. Telephone interviews or counseling sessions prevailed. The most evaluated outcome was medication adherence. When the intervention was remote and of shorter duration, the improvement in medication adherence was up to 8% (P &amp;lt; .05), whereas when a pharmacotherapeutic follow-up service was provided, this improvement reached 59% (P = .002). Pharmaceutical intervention was also associated with a significant improvement in beliefs about medications, patient satisfaction, reduced drug-related problems, and the cost of treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The pharmaceutical care processes should be adjusted to consider the complexity of treatment and patient profiles to produce tailored care plans.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijpp\/riaf029","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T01:25:37Z","timestamp":1748222737000},"page":"243-255","source":"Crossref","is-referenced-by-count":2,"title":["A systematic review of pharmaceutical care interventions in patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"33","author":[{"given":"Alana","family":"Teles Costa","sequence":"first","affiliation":[{"name":"Post-Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe , Sergipe ,","place":["Brazil"]},{"name":"Neuropharmacological Studies Laboratory, Department of Pharmacy, Federal University of Sergipe , Sergipe ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hygor Rafael","family":"da Silva Lima","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe , Sergipe ,","place":["Brazil"]},{"name":"Neuropharmacological Studies Laboratory, Department of Pharmacy, Federal University of Sergipe , Sergipe ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divaldo","family":"Pereira de Lyra J\u00fanior","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe , Sergipe ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"de Oliveira Filho","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe , Sergipe ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6219-2325","authenticated-orcid":false,"given":"Cristiani Isabel","family":"Bander\u00f3 Walker","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe , Sergipe ,","place":["Brazil"]},{"name":"Neuropharmacological Studies Laboratory, Department of Pharmacy, Federal University of Sergipe , Sergipe ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"2025061002120305400_CIT0001","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"2025061002120305400_CIT0002","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"key":"2025061002120305400_CIT0003","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"2025061002120305400_CIT0004","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1185\/03007990903422307","article-title":"Societal cost of rheumatoid arthritis patients in the US","volume":"26","author":"Birnbaum","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"2025061002120305400_CIT0005","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/acr.23425","article-title":"Medical expenditures and earnings losses among US adults with arthritis in 2013","volume":"70","author":"Murphy","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025061002120305400_CIT0006","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41584-022-00827-y","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025061002120305400_CIT0007","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What is rheumatoid arthritis","volume":"327","author":"Smith","year":"2022","journal-title":"JAMA"},{"key":"2025061002120305400_CIT0008","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"2025061002120305400_CIT0009","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.3390\/cells10113017","article-title":"Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies","volume":"10","author":"Mueller","year":"2021","journal-title":"Cells"},{"key":"2025061002120305400_CIT0010","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1007\/s10067-023-06654-0","article-title":"What are the core recommendations for rheumatoid arthritis care? systematic review of clinical practice guidelines","volume":"42","author":"Conley","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2025061002120305400_CIT0011","doi-asserted-by":"publisher","first-page":"e001512","DOI":"10.1136\/rmdopen-2020-001512","article-title":"Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis","volume":"7","author":"Roodenrijs","year":"2021","journal-title":"RMD Open"},{"key":"2025061002120305400_CIT0012","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025061002120305400_CIT0013","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2147\/TCRM.S194921","article-title":"Drug-related problems in patients with rheumatoid arthritis","volume":"15","author":"Ma","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"2025061002120305400_CIT0014","doi-asserted-by":"publisher","first-page":"1759720X2093713","DOI":"10.1177\/1759720X20937132","article-title":"Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients","volume":"12","author":"Thomas","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025061002120305400_CIT0015","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/acr.23343","article-title":"Implementation of treat-to-target for rheumatoid arthritis in the US: analysis of baseline data from a randomized controlled trial","volume":"70","author":"Yu","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025061002120305400_CIT0016","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/BOR.0000000000000602","article-title":"Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices","volume":"31","author":"Day","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2025061002120305400_CIT0017","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/art.40789","article-title":"Chronic opioid use in rheumatoid arthritis: prevalence and predictors","volume":"71","author":"Lee","year":"2019","journal-title":"Arthritis Rheumatology (Hoboken, N.J.)"},{"key":"2025061002120305400_CIT0018","doi-asserted-by":"publisher","first-page":"e1004","DOI":"10.23938\/ASSN.1004","article-title":"Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study)","volume":"45","author":"Caso-Gonz\u00e1lez","year":"2022","journal-title":"An Sist Sanit Navar"},{"key":"2025061002120305400_CIT0019","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2146\/ajhp150727","article-title":"The role of specialty pharmacy drugs in the management of inflammatory diseases","volume":"73","author":"Mullican","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"2025061002120305400_CIT0020","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9131850","article-title":"Quality indicators of pharmaceutical care for integrative healthcare: a scoping review of indicators developed using the delphi technique","volume":"2020","author":"Shawahna","year":"2020","journal-title":"Evid Based Complement Alternat Med."},{"key":"2025061002120305400_CIT0021","volume-title":"Arthritis","author":"Senthelal","year":"2023"},{"key":"2025061002120305400_CIT0022","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/AJP.0b013e31821b6be4","article-title":"Educational interventions by pharmacists to patients with chronic pain","volume":"27","author":"Bennett","year":"2011","journal-title":"Clin J Pain"},{"key":"2025061002120305400_CIT0023","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","article-title":"Medication adherence in gout: a systematic review","volume":"66","author":"De Vera","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025061002120305400_CIT0024","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/AJP.0000000000000063","article-title":"Effectiveness of pharmacist-led medication review in chronic pain management","volume":"30","author":"Hadi","year":"2014","journal-title":"Clin J Pain"},{"key":"2025061002120305400_CIT0025","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/msc.1160","article-title":"Patient satisfaction with pharmacist-led collaborative follow-up care in an ambulatory rheumatology clinic","volume":"15","author":"Hall","year":"2017","journal-title":"Musculoskeletal Care"},{"key":"2025061002120305400_CIT0026","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2025061002120305400_CIT0027","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1590\/S0104-11692007000300023","article-title":"The PICO strategy for the research question construction and evidence search","volume":"15","author":"Santos CM da","year":"2007","journal-title":"Rev Lat Am Enfermagem"},{"key":"2025061002120305400_CIT0028","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2025061002120305400_CIT0029","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0895-4356(90)90158-l","article-title":"High agreement but low Kappa: i. the problems of two paradoxes","volume":"43","author":"Feinstein","year":"1990","journal-title":"J Clin Epidemiol"},{"key":"2025061002120305400_CIT0030","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025061002120305400_CIT0031","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.pec.2013.12.002","article-title":"Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial","volume":"94","author":"Zwikker","year":"2014","journal-title":"Patient Educ Couns"},{"key":"2025061002120305400_CIT0032","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11096-006-9026-6","article-title":"Patient-centred advice is effective in improving adherence to medicines","volume":"28","author":"Clifford","year":"2006","journal-title":"Pharmacy World Science : PWS"},{"key":"2025061002120305400_CIT0033","first-page":"125","article-title":"Design and evaluation of monitoring programme for methotrexate users in the arthritic population - a study at the primary and the secondary care interface","volume":"10","author":"Ekincio\u011flu","year":"2013","journal-title":"Turk J Pharm Sci"},{"key":"2025061002120305400_CIT0034","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/acr.23750","article-title":"Mobile phone text messages and effect on treatment adherence in patients taking methotrexate for rheumatoid arthritis: a randomized pilot study","volume":"71","author":"Mary","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025061002120305400_CIT0035","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11096-007-9134-y","article-title":"The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines","volume":"30","author":"Elliott","year":"2008","journal-title":"Pharmacy World Science : PWS"},{"key":"2025061002120305400_CIT0036","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1111\/bcp.14745","article-title":"Pharmacist-led intervention on chronic pain management: a systematic review and meta-analysis","volume":"87","author":"Thapa","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2025061002120305400_CIT0037","first-page":"21","article-title":"Types of clinical pharmaceutical services: what saith the systematic reviews","volume":"2","author":"Correr","year":"2013","journal-title":"Acta Farmac\u00eautica Portuguesa"},{"key":"2025061002120305400_CIT0038","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ypmed.2017.03.008","article-title":"Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis","volume":"99","author":"Conn","year":"2017","journal-title":"Prev Med"},{"key":"2025061002120305400_CIT0039","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.japh.2022.02.015","article-title":"Effects of pharmacist interventions on pain intensity: systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Veettil","year":"2022","journal-title":"J Am Pharm Assoc: JAPhA"},{"key":"2025061002120305400_CIT0040","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.2174\/1381612043382576","article-title":"The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience","volume":"10","author":"Strand","year":"2004","journal-title":"Curr Pharm Des"},{"key":"2025061002120305400_CIT0041","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5123\/s2176-62232011000300006","article-title":"Assist\u00eancia farmac\u00eautica integrada ao processo de cuidado em sa\u00fade: gest\u00e3o cl\u00ednica do medicamento","volume":"2","author":"Correr","year":"2011","journal-title":"Revista Pan-Amaz\u00f4nica de Sa\u00fade"},{"key":"2025061002120305400_CIT0042","volume-title":"Atenci\u00f3n Farmac\u00eautica: Conceptos, Processos Y Casos Pr\u00e1cticos","author":"D\u00e1der","year":"2008"},{"key":"2025061002120305400_CIT0043","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1001\/jama.260.12.1743","article-title":"The quality of care. How can it be assessed","volume":"260","author":"Donabedian","year":"1988","journal-title":"JAMA"},{"key":"2025061002120305400_CIT0044","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"2025061002120305400_CIT0045","doi-asserted-by":"publisher","first-page":"e0210312","DOI":"10.1371\/journal.pone.0210312","article-title":"Pharmacist-participated medication review in different practice settings: service or intervention? an overview of systematic reviews","volume":"14","author":"Silva","year":"2019","journal-title":"PLoS One"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/3\/243\/63350082\/riaf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/3\/243\/63350082\/riaf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:12:08Z","timestamp":1749535928000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/33\/3\/243\/8148736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5,24]]},"published-print":{"date-parts":[[2025,6,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riaf029","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,24]]}}}